PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.
Click the orange button to the right to learn more.
Surgery for Brain Cancer: What Patients Need to Know. Brain cancer surgery is different from surgery for most other cancers. The surgeon is not simply trying to remove as much cancer as possible. The goal is to remove as much tumor as can be safely removed while protecting the brain functions that control movement, speech, memory, vision, sensation, and other essential abilities.
Brain cancer is a unique type of cancer. Brain cancer surgery is often only the first step in treatment. Learn more about Radiation for Cancer – What Patients Need to Know and how radiation may be incorporated into treatment after surgery.
If chemotherapy becomes part of your treatment plan, see Chemotherapy for Cancer – What Patients Need to Know for an overview of how chemotherapy works, common side effects, and questions to ask your oncology team.
For some patients, surgery can be the first and most important step in treatment. For others, a biopsy may be safer than attempting to remove the entire tumor. And for some brain tumors—particularly certain metastatic tumors—radiation, systemic therapy, or a combination of treatments may be more appropriate.
This article explains what patients and families should know before agreeing to brain tumor surgery, including the different types of surgery, how surgeons decide how much tumor to remove, potential risks, recovery, and questions to ask a neurosurgeon.
PeopleBeatingCancer perspective: A brain cancer diagnosis is one of the situations where getting a second opinion from a multidisciplinary neuro-oncology team can be particularly valuable. The location and biology of a brain tumor can make the difference between a tumor that is safely resectable and one where attempting complete removal could cause permanent neurological damage.
I am a long-term survivor of an incurable blood cancer called multiple myeloma. My research and experience with evidence-based non-conventional therapies are the reason why I have lived in complete remission from my incurable blood cancer since achieving complete remission in early 1999. I have learned that the best way to manage cancer is to combine the best of conventional and evidence-based non-conventional therapies.
I have come to believe that therapy-induced side effects can be life-threatening while ruining quality of life. Consider therapies shown to reduce possible side effects.
Scroll down the page and post a question or a comment if there’s anything you’d like to know about radiation for cancer.
Good luck,
Brain cancer surgery is an operation performed to remove a brain tumor, obtain tissue for diagnosis, relieve pressure inside the skull, or improve symptoms caused by the tumor.
The two broad categories are:
The National Cancer Institute identifies two major goals of brain tumor surgery: establishing a diagnosis and reducing pressure caused by the tumor while preserving neurological function.
Importantly, “complete removal” does not always mean that every cancer cell has been eliminated.
Many malignant brain tumors infiltrate surrounding brain tissue. Cancer cells may extend beyond what can be seen on an MRI or what the surgeon can distinguish visually during an operation.
Consequently, surgery is often followed by radiation therapy, chemotherapy, targeted therapy, or another treatment.
Consider the difference between removing a tumor from the colon and removing one from the brain.
A surgeon can sometimes remove a section of the colon containing a tumor and reconnect the remaining bowel.
The brain is different.
A tumor may be located next to the areas responsible for:
Removing additional tumor tissue may potentially improve cancer control—but if that tissue is part of functioning brain, the operation could cause permanent neurological disability.
That creates the central question in brain tumor surgery:
How much tumor can be removed without causing unacceptable damage to normal brain function?
Current neuro-oncology guidance emphasizes that preventing a new permanent neurological deficit takes priority over maximizing the percentage of tumor removed.
The purpose of surgery depends on the type, size, location, and biology of the tumor.
Sometimes imaging strongly suggests that a person has a brain tumor but cannot establish exactly what type it is.
A biopsy provides tissue that can be examined by a pathologist.
Modern brain tumor diagnosis may involve much more than looking at cells under a microscope. Molecular testing can help determine the tumor’s classification and may influence treatment and prognosis.
When a tumor can be safely accessed, the neurosurgeon may attempt a resection.
The objective is generally not simply “maximum removal.”
It is better described as:
Maximum safe resection.
A growing tumor can occupy space inside the skull and compress surrounding brain tissue.
Removing tumor tissue can relieve this pressure and potentially improve neurological symptoms.
Surgery can sometimes improve symptoms caused by the tumor, including:
Seizures are among the common symptoms associated with brain tumors, and in selected patients, tumor surgery may also help control tumor-related seizures.
Reducing the amount of tumor remaining can make subsequent radiation or systemic treatment part of a broader treatment strategy.
These procedures are not the same.
A biopsy removes a small amount of tumor tissue.
A stereotactic biopsy uses imaging and specialized equipment to guide the surgeon to the tumor.
Biopsy may be preferred when:
The NCI notes that stereotactic biopsy can be used for lesions that are difficult to reach and resect.
Resection means surgically removing tumor tissue.
Depending on the circumstances, the surgeon may perform:
The terminology can vary between studies and medical centers, so patients should ask their surgeon exactly what percentage or volume of tumor they expect to remove.
A craniotomy is one of the most common approaches used for brain tumor surgery.
During a craniotomy:
The NCI provides an overview of craniotomy as an operation in which a section of the skull is temporarily removed to provide access to the brain.
The phrase “awake brain surgery” can sound frightening.
In reality, awake craniotomy is a specialized technique used for selected tumors located near areas of the brain responsible for important functions such as speech and movement.
The patient may be awake for part of the operation, so the surgical team can test neurological functions while the tumor is being removed.
The patient might be asked to:
This allows the surgical team to identify important functional brain regions and avoid damaging them.
The NCI notes that cooperative patients can undergo awake craniotomy with real-time neurological assessment during tumor removal.
Not every patient or tumor is appropriate for an awake craniotomy.
Brain tumor surgery increasingly relies on technology designed to distinguish tumor from healthy brain and to identify important neurological pathways.
Depending on the tumor and medical center, surgeons may use:
The purpose is not simply to remove more tissue.
The purpose is to remove more tumor while protecting functioning brain.
This is one of the most important—and complicated—questions patients should ask.
Research in glioblastoma has repeatedly found an association between greater extent of tumor resection and improved survival.
For example, a large systematic review and meta-analysis involving more than 41,000 patients found lower mortality among patients undergoing gross total resection compared with subtotal resection. However, the authors also rated the quality of the evidence as moderate to low.
A later meta-analysis focused on modern WHO-defined IDH-wild-type glioblastoma similarly found longer overall and progression-free survival associated with gross total resection, although the researchers emphasized limitations caused by differences among the studies.
There is an important caveat.
Association does not necessarily prove that removing more tumor itself causes longer survival.
Tumors that are easier and safer to remove may also have more favorable biological characteristics. Patients who are healthier may also be more likely to undergo extensive surgery.
The EANO guidelines therefore make an important distinction: efforts to achieve complete resection are justified, but preventing permanent neurological deficits takes priority.
Don’t ask only:
“Can you remove the whole tumor?”
Also ask:
“What is the maximum safe resection for my particular tumor, and what neurological functions are at risk if you try to remove more?”
That is a much more useful question.
Leaving tumor behind does not necessarily mean that surgery was unsuccessful.
Sometimes the safest operation is to deliberately leave tumor tissue behind because removing it would risk permanent neurological damage.
The remaining tumor may then be treated with:
The treatment plan depends heavily on the tumor’s pathology and molecular characteristics.
The NCI notes that patients with adult CNS tumors may receive surgery followed by radiation, chemotherapy, targeted therapy, or clinical-trial approaches depending on tumor type and circumstances.
Not every brain tumor began in the brain.
Cancer from another part of the body can spread to the brain. These are called brain metastases.
Common primary cancers that can metastasize to the brain include:
Surgery can be particularly useful for selected patients with a large or symptomatic brain metastasis, especially when it is causing pressure on surrounding brain tissue.
Current multidisciplinary guidelines emphasize that surgery is most useful in selected patients, with factors such as tumor size, number of metastases, symptoms, overall health, and control of cancer elsewhere in the body influencing the decision.
For some patients, stereotactic radiosurgery may be used instead of surgery or after surgery.
Therefore:
A brain metastasis does not automatically mean that surgery is required—or that surgery is inappropriate.
The decision should be individualized.
Brain surgery is major surgery.
Potential complications include:
The exact risks depend heavily on the tumor’s location.
A tumor located near the motor cortex may carry different risks than a tumor located near language centers or deep structures of the brain.
NCI notes that surgery can cause complications including infection, bleeding, damage to nearby tissues, and anesthesia-related problems.
“What is the risk that I will have a permanent neurological deficit after surgery?”
Ask the surgeon to explain this in plain language.
After surgery, patients are closely monitored.
Depending on the procedure, you may spend time in:
The medical team may monitor:
An MRI or CT scan may be performed soon after surgery to determine how much tumor remains and to evaluate the brain following the procedure.
EANO guidance recommends postoperative imaging within approximately 24–48 hours for diffuse gliomas, including sequences that can help distinguish residual tumor from postoperative changes.
Recovery varies enormously.
Some patients experience relatively rapid recovery.
Others need weeks or months of rehabilitation.
Recovery may involve:
For weakness, balance problems, walking difficulties, or coordination problems.
To help patients regain the ability to perform everyday activities.
For problems involving speech, language, swallowing, or cognitive communication.
For problems involving:
Rehabilitation is not an admission of failure.
It is part of brain cancer treatment for many patients.
NCI describes physical and rehabilitation specialists working with brain tumor patients to restore abilities affected by the tumor or its treatment.
There is no single recovery timetable.
Recovery depends on:
Some patients may return home within several days.
Others may require inpatient rehabilitation or substantial assistance at home.
Patients should plan for the possibility that they will need help with:
A strong caregiver and family support system can be extremely valuable during recovery.
Possibly.
Surgery is often only the first part of treatment for malignant brain tumors.
For example, the NCI lists surgery followed by radiation and chemotherapy among standard treatment approaches for glioblastoma.
The need for additional treatment depends on:
This is why the pathology and molecular report following surgery is so important.
Before surgery, consider taking a written list of questions.
For a major brain operation, a second opinion can be particularly valuable.
Consider seeking consultation at a comprehensive neuro-oncology center where neurosurgeons, neuro-oncologists, radiation oncologists, neuroradiologists, neuropathologists, rehabilitation specialists, and other experts regularly work together.
A second opinion may answer questions such as:
A second opinion does not necessarily mean changing doctors.
It can simply mean obtaining more information before making an irreversible decision.
For most patients with malignant brain cancer, the long-term treatment plan involves more than surgery.
Depending on the tumor, treatment may include:
Diagnosis → Surgery/Biopsy → Pathology & Molecular Testing → Radiation and/or Drug Therapy → Rehabilitation → Surveillance
For metastatic brain tumors, the pathway may be different:
Primary Cancer → Brain Imaging → Multidisciplinary Evaluation → Surgery and/or Stereotactic Radiation → Systemic Therapy → Follow-up
The important point is that brain cancer treatment should be individualized.
There is no universal “best” brain cancer surgery.
Evidence Rating: Moderate
What is well established: Surgery can provide tissue for diagnosis, relieve pressure, improve symptoms, and remove the tumor in appropriately selected patients.
What is supported but more complicated: Greater extent of resection is associated with improved outcomes in glioblastoma and other gliomas. Multiple systematic reviews support this association, but much of the evidence is observational and therefore cannot completely establish cause and effect.
Most important clinical limitation: Removing more tumor is not automatically better if doing so causes permanent neurological damage. Current guidelines emphasize maximum safe resection rather than tumor removal at any cost.
For brain metastases: The role of surgery depends strongly on tumor size, number, symptoms, location, overall health, systemic disease, and available radiation/systemic therapies.
Adult Central Nervous System Tumors Treatment (PDQ)
NCI: Adult Central Nervous System Tumors Treatment
Central Nervous System Tumors Treatment – Health Professional Version
NCI: CNS Tumors Treatment (Health Professional)
Brown et al., JAMA Oncology — Association of the Extent of Resection With Survival in Glioblastoma: Systematic Review and Meta-analysis
PubMed research article
Jusue-Torres et al. — Effect of Extent of Resection on Survival in IDH-Wild-Type Glioblastoma
PubMed research article
Revilla-Pacheco et al. — Extent of Resection and Survival in Glioblastoma
PubMed research article
EANO Guidelines on Diagnosis and Treatment of Diffuse Gliomas of Adulthood
EANO guideline — full text on PubMed Central
ASCO-SNO-ASTRO Guideline: Treatment for Brain Metastases
PubMed — Treatment for Brain Metastases Guideline
ASTRO Clinical Practice Guideline: Radiation Therapy for Brain Metastases
PubMed — ASTRO Brain Metastases Guideline